Matthew Henn

Matthew Henn

Company: Seres Therapeutics

Job title: Executive VP & CSO


Developing Bacterial Consortia Therapeutics for Infectious and Inflammatory Disease Targets 10:30 am

• Providing an update on Seres’ clinical and pre-clinical pipeline • Discussing candidates including SER-109, which in a Phase 3 Clinical Trial led to a statistically significant reduction in C.difficile recurrenceRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.